XERIS PHARMACEUTICALS INC Accounts Receivable
XERIS PHARMACEUTICALS INC had Accounts Receivable of $6.88 million as of 2020-12-31, per its 10-K filed 2021-03-09.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2021-03-09
- 2020-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $6.88M.
- 2019-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $4.69M.
- 2019-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $874.00K.
- 2019-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $826.00K.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2020-12-31 | $6.88M 10-K · filed 2021-03-09 | |
| 2019-12-31 | $4.69M 10-K · filed 2021-03-09 | |
| 2019-09-30 | $874.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $826.00K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $3.63M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $0.00 10-K · filed 2020-03-12 | $2.87M 10-K · filed 2019-03-06 |
| 2018-09-30 | $1.73M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $1.06M 10-Q · filed 2018-08-14 | |
| 2017-12-31 | $1.20M 10-K · filed 2019-03-06 |